Daily Dose - Apr 14th, 2026
Daily Dose |
View online
April 14, 2026
US drug supply at risk from single-country KSM sources: report
New data from USP reveals that 48 of the 100 vulnerable U.S. medicines are dependent on a key starting material sourced from at least one country.
Read More
Regeneron, Telix partner on radiopharmaceutical development
The collaboration integrates radiopharma manufacturing with antibody platforms to support scalable production and development of targeted oncology therapies.
Read More
OXB launches fast-track viral vector manufacturing service
The service integrates upstream and downstream processes to reduce timelines to GMP production for eligible cell and gene therapy programs.
Read More